ScholarIQanswers from OpenAlex & ORCID
Mark Krailo
ResearcherPublications, citations & collaboration network
Mark Krailo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark Krailo have?
ScholarIQindexed works
Mark Krailo has 531 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark Krailo have?
ScholarIQcitation count
Mark Krailo has 31,286 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark Krailo?
ScholarIQh-index
Mark Krailo has an h-index of 95 in OpenAlex.
What is the i10-index of Mark Krailo?
ScholarIQi10-index
Mark Krailo has an i10-index of 311 in OpenAlex.
What is the ORCID of Mark Krailo?
ScholarIQorcid
The ORCID for Mark Krailo is on the source record.
What is the OpenAlex record for Mark Krailo?
ScholarIQopenalex
The OpenAlex for Mark Krailo is on the source record.
What are the most-cited papers on Mark Krailo?
ScholarIQmost cited works
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration
Rebecka L. Meyers, Rudolf Maibach, Eiso Hiyama, Beate Häberle, Mark Krailo, Arun Rangaswami, Daniël C. Aronson, Marcio H. Malogolowkin, Giorgio Perilongo, Dietrich von Schweinitz, Marc Ansari, Dolores López‐Terrada, Yukichi Tanaka, Rita Alaggio, Ivo Leuschner, Tomoro Hishiki, Irene Schmid, Kenichiro Watanabe, Kenichi Yoshimura, Yurong Feng, Eugenia Rinaldi, Davide Saraceno, Marisa DeRosa, Piotr Czauderna
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan, Neyssa Marina, Gordana Jovic, Jane Hook, Mark Krailo, Mark C. Gebhardt, Zsuzsanna Pápai, James S. Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen M. Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul A. Meyers, Richard Görlick, Reinhard Windhager, K. Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula J. Schomberg, Per‐Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerß, Trude Butterfaß‐Bahloul, Carol D. Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark L. Bernstein
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
Jeremy Whelan, Stefan Bielack, Neyssa Marina, Sigbjørn Smeland, Gordana Jovic, Jane Hook, Mark Krailo, Jakob Anninga, Trude Butterfaß‐Bahloul, Tom Böhling, Gabriele Calaminus, Michael Capra, Claudia Deffenbaugh, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Hans Gelderblom, Allen M. Goorin, Richard Görlick, Georg Gosheger, R. J. Grimer, Kirsten Sundby Hall, K. Helmke, Pancras C.W. Hogendoorn, Gernot Jundt, Leo Kager, Thomas Kuehne, Ching C. Lau, G. Douglas Letson, James S. Meyer, Paul A. Meyers, Carol D. Morris, Hubert Mottl, Helen Nadel, Rajaram Nagarajan, R. Lor Randall, Paula J. Schomberg, R. Schwarz, Lisa A. Teot, Matthew R. Sydes, Mark L. Bernstein, James D. Pickering, Nicola Joffe, Matthias Kevric, Benjamin Sorg, Doojduen Villaluna, Caroline Wang, Martha Perisoglou, Leonardo Trani, Jenny Potratz, D. Carrle, Miriam Wilhelm, Katja Zils, C. Teske